X-11112062-T-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_005333.5(HCCS):āc.2T>Cā(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.000000921 in 1,086,313 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ).
Frequency
Genomes: not found (cov: 24)
Exomes š: 9.2e-7 ( 0 hom. 0 hem. )
Consequence
HCCS
NM_005333.5 start_lost
NM_005333.5 start_lost
Scores
5
4
5
Clinical Significance
Conservation
PhyloP100: 5.11
Genes affected
HCCS (HGNC:4837): (holocytochrome c synthase) The protein encoded by this gene is an enzyme that covalently links a heme group to the apoprotein of cytochrome c. Defects in this gene are a cause of microphthalmia syndromic type 7 (MCOPS7). Three transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-11112062-T-C is Pathogenic according to our data. Variant chrX-11112062-T-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3064959.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HCCS | NM_005333.5 | c.2T>C | p.Met1? | start_lost | 2/7 | ENST00000380762.5 | NP_005324.3 | |
HCCS | NM_001122608.3 | c.2T>C | p.Met1? | start_lost | 2/7 | NP_001116080.1 | ||
HCCS | NM_001171991.3 | c.2T>C | p.Met1? | start_lost | 2/7 | NP_001165462.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HCCS | ENST00000380762.5 | c.2T>C | p.Met1? | start_lost | 2/7 | 1 | NM_005333.5 | ENSP00000370139.4 | ||
HCCS | ENST00000380763.7 | c.2T>C | p.Met1? | start_lost | 2/7 | 1 | ENSP00000370140.3 | |||
HCCS | ENST00000321143.8 | c.2T>C | p.Met1? | start_lost | 2/7 | 2 | ENSP00000326579.4 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD3 genomes
Cov.:
24
GnomAD4 exome AF: 9.21e-7 AC: 1AN: 1086313Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 352737
GnomAD4 exome
AF:
AC:
1
AN:
1086313
Hom.:
Cov.:
28
AF XY:
AC XY:
0
AN XY:
352737
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 24
GnomAD4 genome
Cov.:
24
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Linear skin defects with multiple congenital anomalies 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 25, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;T
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;.;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
PROVEAN
Benign
N;N;N
REVEL
Uncertain
Sift
Pathogenic
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
B;B;B
Vest4
MutPred
Gain of glycosylation at M1 (P = 0.0075);Gain of glycosylation at M1 (P = 0.0075);Gain of glycosylation at M1 (P = 0.0075);
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.